查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1515444

基因組生物標記市場，按類型、疾病適應症、驗證、最終用戶和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Genomic Biomarker Market, By Type, By Disease Indication, By Validation, By End User, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023 年，基因組生物標記市場規模為 76.842 億美元，2024 年至 2032 年複合年成長率為 18.20%。

基因組生物標記市場-市場動態

癌症盛行率不斷上升推動市場成長

由於肺癌、前列腺癌、卵巢癌和乳腺癌等各種癌症的盛行率不斷上升，預計對基因組生物標記的市場需求將會增加。針對器官系統和疾病是人類健康生物標記的目標。特別是，生物標記在治療、重症監護和基於疾病的診斷的醫療程序中變得越來越常見。為了改善包括癌症和心血管疾病在內的慢性疾病的檢測和管理，全世界對遺傳生物標記的需求日益成長。這導致預計期內市場對基因組生物標記的需求增加。

基因組生物標記市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 18.20% 左右的複合年成長率成長

根據類型細分，預測生物標記類別預計將在 2023 年顯示最大的市場佔有率

依疾病適應症細分，2023年腫瘤類別為主導類型

基於終端用戶細分，診斷品類為2023年主導類型

按地區分類，北美是 2023 年的主要收入來源

基因組生物標記市場-細分分析：

全球基因組生物標記市場根據類型、疾病適應症、驗證、最終用戶和地區進行細分。

市場根據類型分為兩類：預測生物標記和預後生物標記。預測生物標誌類別主導市場。此細分市場受益的原因是預測生物標記是治療前或基線資料，表明患者從特定治療中受益或不受益的可能性。當創建特定的治療藥物時，通常選擇預測生物標記作為伴隨生物標記。腫瘤學中的一個常見例子是一種生物標記物，如果它能夠識別生長因子蛋白Her-2 的過度表現（這種蛋白會導致乳癌細胞增殖），那麼該生物標記就可以用來預測何時施用曲妥珠單抗（赫賽汀）。對於乳癌患者，這種藥物可以阻斷 Her-2 的作用。因此，對預測性生物標記的需求隨之成長。鑑於上述說法，可以推斷，在預測期內，該細分市場將擁有最大的市場佔有率。

根據疾病適應症，市場分為以下幾類：腫瘤、心血管疾病、神經系統疾病、腎臟疾病等。腫瘤學類別在市場中佔據主導地位，並可能在預測期內保持其主導地位。全球癌症患者數量的不斷增加以及生物標記方法不斷取得的技術突破是造成這一重大利害關係的原因。近年來，基因組生物標記在腫瘤學中有許多可能的用途，包括風險評估、預測確定、鑑別診斷篩檢、追蹤癌症病程和治療反應預測。根據世界衛生組織 (WHO) 的數據，癌症是全球第二大常見死因，佔低收入和中等收入國家死亡人數的 70%。此外，根據世界衛生組織估計，2018 年全球報告的癌症死亡人數為 960 萬人，新增癌症病例為 1,810 萬例。

基因組生物標記市場-地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

在預測期內，北美預計將佔據全球基因組生物標記市場的最大佔有率。該地區飲食和生活方式的轉變導致慢性病發病率不斷上升，這將確保其主導地位。由於製藥業擴大使用技術，基因組生物標記市場不斷成長。由於美國、加拿大等國家加強研發力度，基因組生物標記市場預計將成長。

此外，預計亞太地區的基因組生物標記市場將以全球最快的速度擴張。預計對該地區市場擴張貢獻最大的國家為中國、日本、韓國和印度。公共和私人組織為推動製藥業的發展投入了大量資金，支持亞太市場的擴張。預計亞太地區市場的擴張將受到對各種基因檢測計劃和與醫療保健行業進步相關的研究的日益重視的推動。

基因組生物標記市場-競爭格局：

基因組生物標記市場的主要參與者包括 Thermo Fisher Scientific（美國）、F. Hoffmann-La Roche Ltd（瑞士）、Myriad Genetics, Inc（美國）、Eurofins Scientific（盧森堡）和 QIAGEN（德國）等。強調的一項或多項成長策略是併購；其他策略包括有關合作夥伴之間策略協作、相互協議和夥伴關係的趨勢和分析。為了擴大其地理影響力，各大公司正在實施新產品發布的前沿策略。

最近的發展：

2023 年 5 月：英國 MHRA 和 Genomics England 聯合表示，他們已成立一家合資企業，開發尖端資源，以了解一個人的基因組成如何影響藥物的安全性。

2023 年 5 月：京都大學、富士通和 Chordia Therapeutics 宣佈建立策略夥伴關係，開始一項旨在識別新型癌症治療生物標記的人工智慧試驗。這些發現促成了合作的目標，即開發適合每位患者的新型癌症療法。

2022 年 10 月：北卡羅來納州的 Biofidelity 推出首款商業產品，表示將資助 2,300 萬美元來維持其肺癌的 ASPYRE-Lung 診斷檢測。

目錄

第 1 章：基因組生物標記市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的基因組生物標記市場片段
    • 依疾病指示分類的基因組生物標記市場片段
    • 經驗證的基因組生物標記市場片段
    • 最終用戶的基因組生物標記市場片段
    • 按國家/地區分類的基因組生物標記市場片段
    • 按地區分類的基因組生物標記市場片段
  • 競爭洞察

第 3 章：基因組生物標記主要市場趨勢

  • 基因組生物標記市場促進因素
    • 市場促進因素的影響分析
  • 基因組生物標記市場限制
    • 市場限制影響分析
  • 基因組生物標記市場機會
  • 基因組生物標記市場未來趨勢

第 4 章：基因組生物標記產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：基因組生物標記市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：基因組生物標記市場格局

  • 2023 年基因組生物標記市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：基因組生物標記市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 預測性生物標記
    • 預後生物標記

第 8 章：基因組生物標記市場 - 依疾病指示

  • 概述
    • 按疾病適應症分類的細分市場佔有率分析
    • 腫瘤學
    • 心血管疾病
    • 神經系統疾病
    • 腎臟疾病
    • 其他

第 9 章：基因組生物標記市場 - 透過驗證

  • 概述
    • 透過驗證進行細分市場佔有率分析
    • 分析驗證
    • 臨床驗證
    • 臨床實用性

第 10 章：基因組生物標記市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 診斷
    • 研究實驗室
    • 醫院
    • 其他

第 11 章：基因組生物標記市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美基因組生物標記主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模與預測（按疾病適應症）
    • 北美市場規模與預測（經驗證）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲基因組生物標記主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按疾病適應症）
    • 歐洲市場規模與預測（經驗證）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區基因組生物標記主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（依疾病適應症）
    • 亞太地區市場規模與預測（經驗證）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲基因組生物標記主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按疾病適應症）
    • 拉丁美洲市場規模與預測（經驗證）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲基因組生物標記主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（依疾病指示）
    • 中東和非洲市場規模和預測（經驗證）
    • 中東和非洲市場規模及預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 基因組生物標記產業

  • 競爭儀表板
  • 公司簡介
    • Thermo Fisher Scientific (US)
    • F. Hoffmann-La Roche Ltd (Switzerland)
    • Eurofins Scientific (Luxembourg)
    • FOUNDATION MEDICINE, INC. (US)
    • QIAGEN (Germany)
    • Myriad Genetics, Inc (US)
    • Bio-Rad Laboratories, Inc. (US)
    • MedGenome (India)
    • Sema4 (US)
    • GENOME LIFE SCIENCES (India)
    • Almac Group (UK)
    • Creative Diagnostics (US)
    • Quanterix (US)
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV3172

REPORT HIGHLIGHT

Genomic Biomarker Market size was valued at USD 7,684.2 Million in 2023, expanding at a CAGR of 18.20% from 2024 to 2032.

Genomic biomarkers are characteristics of DNA and RNA that are used to characterize diseases, choose treatments, and provide diagnostic information. Genomic biomarkers reflect pathological and physiological processes, as well as the reaction of the organism to treatment. One gene, a collection of genes, or the entire genome can have molecular alterations discovered by genomic biomarker testing. There may or may not be substantial supporting evidence for a connection between a genetic biomarker and the risk of contracting a disease. The clinical validity and usefulness of genomic biomarkers are influenced by two factors: genetic epidemiology data and functional laboratory assessments.

Genomic Biomarker Market- Market Dynamics

Growing Cancer Prevalence to Propel Market Growth

The market demand for genomics biomarkers is expected to increase due to the rising prevalence of various cancers, including lung, prostate, ovarian, and breast cancer. Targeting organ systems and diseases is the goal of biomarkers in human health. In particular, biomarkers are becoming more and more common in medical procedures that lead to therapy, critical care, and disease-based diagnosis. There is a growing need for genetic biomarkers worldwide in order to improve the detection and management of chronic illnesses, including cancer and cardiovascular disease. This leads to an increase in the market's demand for genomics biomarkers during the projected term.

Genomic Biomarker Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 18.20% over the forecast period (2024-2032)

Based on type segmentation, the predictive biomarkers category was predicted to show maximum market share in the year 2023

Based on disease indication segmentation, the oncology category was the leading type in 2023

Based on end user segmentation, the diagnostic category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Genomic Biomarker Market- Segmentation Analysis:

The Global Genomic Biomarker Market is segmented on the basis of Type, Disease Indication, Validation, End User, and Region.

The market is divided into two categories based on type: Predictive Biomarkers and Prognostic Biomarkers. The predictive biomarkers category dominates the market. The reason the segment benefits is that predictive biomarkers are pretreatment or baseline data that indicate a patient's likelihood of benefiting or not from a particular treatment. When creating a particular therapeutic drug, a predictive biomarker is often selected as a companion biomarker. A common example in oncology is a biomarker that might be used to forecast when to administer trastuzumab (Herceptin) if it can identify the overexpression of the growth factor protein Her-2, which gives rise to cell proliferation in breast cancer cells. For patients with breast cancer, this medication blocks the actions of Her-2. Thus, the need for predictive biomarkers has grown as a result. Given the aforementioned claims, it can be inferred that over the forecast period, the market segment will have the greatest market share.

The market is divided into the following categories based on disease indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. The expanding number of cancer patients worldwide and the increasing technological breakthroughs in biomarker approaches are responsible for the significant stake. Recent years have seen a number of possible uses for genomic biomarkers in oncology, including risk assessment, predictive determination, screening for differential diagnoses, tracking the course of cancer, and therapy response prediction. As per the World Health Organization (WHO), cancer ranks as the second most common cause of death worldwide, taking into consideration 70% of fatalities in low- and middle-income nations. Additionally, according to WHO estimates, there were 9.6 million cancer deaths and 18.1 million new cases of cancer reported worldwide in 2018.

Genomic Biomarker Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for genomic biomarker. The increasing incidence of chronic illnesses brought on by the region's shifting dietary and lifestyle patterns will ensure its domination. The market for genomics biomarkers grew as a result of the pharmaceutical industry's increased use of technology. The genomic biomarker market is expected to rise as a result of increased research and development initiatives being implemented in nations like the United States, Canada, etc.

In addition, the genomic biomarker market is anticipated to expand at the fastest rate in the world during the projected period in Asia Pacific. The countries that are anticipated to have contributed the most to the market's expansion in the area are China, Japan, South Korea, and India. The significant sums of money that both public and private organizations have invested in the advancement of the pharmaceutical sector support the expansion of the Asia Pacific market. The market's expansion in Asia Pacific is anticipated to be fueled by the growing emphasis on various genetic testing initiatives and research related to the advancement of the healthcare sector.

Genomic Biomarker Market- Competitive Landscape:

Key players in the Genomic Biomarkers market include, Thermo Fisher Scientific (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Myriad Genetics, Inc (U.S.), Eurofins Scientific (Luxembourg), and QIAGEN (Germany), among others. One or more of the growth tactics highlighted is mergers and acquisitions; other strategies include trends and analysis regarding strategic collaboration among partners, mutual agreements, and partnerships. To increase their geographic presence, the major firms are implementing cutting-edge strategies for new product releases.

Recent Developments:

May 2023: The UK MHRA and Genomics England jointly stated that they have formed a joint venture to develop cutting-edge resources to comprehend how a person's genetic composition affects the safety of medications.

May 2023: The announcement was made by Kyoto University, Fujistsu, and Chordia Therapeutics regarding their strategic partnership to begin an AI trial aimed at identifying biomarkers for novel cancer treatments. These findings have led to the collaboration's goal of developing novel cancer therapies that are tailored to each patient.

October 2022: Launching its first commercial product, Biofidelity of North Carolina said that it is funding $23 million to maintain its ASPYRE-Lung diagnostic assay for lung cancer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENOMIC BIOMARKER MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific (U.S.)

F. Hoffmann-La Roche Ltd (Switzerland)

Eurofins Scientific (Luxembourg)

FOUNDATION MEDICINE, INC. (U.S.)

QIAGEN (Germany)

Myriad Genetics, Inc (U.S.)

Bio-Rad Laboratories, Inc. (U.S.)

MedGenome (India)

Sema4 (U.S.)

GENOME LIFE SCIENCES (India)

Almac Group (U.K.)

Creative Diagnostics (U.S.)

Quanterix (U.S.)

Others

GLOBAL GENOMIC BIOMARKER MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Predictive Biomarkers
  • Prognostic Biomarkers

GLOBAL GENOMIC BIOMARKER MARKET, BY DISEASE INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Renal Disorders
  • Others

GLOBAL GENOMIC BIOMARKER MARKET, BY VALIDATION- MARKET ANALYSIS, 2019 - 2032

  • Analytical Validation
  • Clinical Validation
  • Clinical Utility

GLOBAL GENOMIC BIOMARKER MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Diagnostic
  • Research Laboratories
  • Hospitals
  • Others

GLOBAL GENOMIC BIOMARKER MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genomic Biomarker Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genomic Biomarker Market Snippet by Type
    • 2.1.2. Genomic Biomarker Market Snippet by Disease Indication
    • 2.1.3. Genomic Biomarker Market Snippet by Validation
    • 2.1.4. Genomic Biomarker Market Snippet by End User
    • 2.1.5. Genomic Biomarker Market Snippet by Country
    • 2.1.6. Genomic Biomarker Market Snippet by Region
  • 2.2. Competitive Insights

3. Genomic Biomarker Key Market Trends

  • 3.1. Genomic Biomarker Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genomic Biomarker Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genomic Biomarker Market Opportunities
  • 3.4. Genomic Biomarker Market Future Trends

4. Genomic Biomarker Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genomic Biomarker Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genomic Biomarker Market Landscape

  • 6.1. Genomic Biomarker Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genomic Biomarker Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Predictive Biomarkers
    • 7.1.3. Prognostic Biomarkers

8. Genomic Biomarker Market - By Disease Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Indication, 2023 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Cardiovascular Diseases
    • 8.1.4. Neurological Diseases
    • 8.1.5. Renal Disorders
    • 8.1.6. Others

9. Genomic Biomarker Market - By Validation

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Validation, 2023 & 2032 (%)
    • 9.1.2. Analytical Validation
    • 9.1.3. Clinical Validation
    • 9.1.4. Clinical Utility

10. Genomic Biomarker Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Diagnostic
    • 10.1.3. Research Laboratories
    • 10.1.4. Hospitals
    • 10.1.5. Others

11. Genomic Biomarker Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Genomic Biomarker Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Genomic Biomarker Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Genomic Biomarker Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Genomic Biomarker Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Genomic Biomarker Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Disease Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Validation, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Genomic Biomarker Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Thermo Fisher Scientific (U.S.)
    • 12.2.2. F. Hoffmann-La Roche Ltd (Switzerland)
    • 12.2.3. Eurofins Scientific (Luxembourg)
    • 12.2.4. FOUNDATION MEDICINE, INC. (U.S.)
    • 12.2.5. QIAGEN (Germany)
    • 12.2.6. Myriad Genetics, Inc (U.S.)
    • 12.2.7. Bio-Rad Laboratories, Inc. (U.S.)
    • 12.2.8. MedGenome (India)
    • 12.2.9. Sema4 (U.S.)
    • 12.2.10. GENOME LIFE SCIENCES (India)
    • 12.2.11. Almac Group (U.K.)
    • 12.2.12. Creative Diagnostics (U.S.)
    • 12.2.13. Quanterix (U.S.)
    • 12.2.14. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Genomic Biomarker Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Genomic Biomarker Market, by Type 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Disease Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Indication
  • TABLE Global Genomic Biomarker Market, by Disease Indication 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Validation Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Validation
  • TABLE Global Genomic Biomarker Market, by Validation 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Genomic Biomarker Market, by End User 2019-2032 (USD Million)
  • TABLE Genomic Biomarker Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Genomic Biomarker Market, by Region 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE North America Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Europe Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Asia Pacific Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Latin America Genomic Biomarker Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Disease Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by Validation, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Genomic Biomarker Market, by End User, 2019-2032 (USD Million)

List of Figures

  • FIGURE Genomic Biomarker Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Disease Indication segment market share analysis, 2023 & 2032
  • FIGURE Disease Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Validation segment market share analysis, 2023 & 2032
  • FIGURE Validation segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2032
  • FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Genomic Biomarker Market share and leading players, 2023
  • FIGURE Europe Genomic Biomarker Market share and leading players, 2023
  • FIGURE Asia Pacific Genomic Biomarker Market share and leading players, 2023
  • FIGURE Latin America Genomic Biomarker Market share and leading players, 2023
  • FIGURE Middle East and Africa Genomic Biomarker Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Germany Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Genomic Biomarker Market share analysis by country, 2023
  • FIGURE India Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Brazil Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Genomic Biomarker Market share analysis by country, 2023
  • FIGURE Saudi Arabia Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Genomic Biomarker Market size, forecast and trend analysis, 2019 to 2032 (USD Million)